GSK's Nucala approved in China for use in severe asthma : co

GSK's Nucala approved in China for use in severe asthma

Related Keywords

China , Israel , United Kingdom , United States , Washington , American , Chinese , Kaivan Khavandi , Menzies Gowa Co Morbidities , Drug Administration , Group Phase , European Union , Chinese Thoracic Society , Blood Institute , Chinese Society Of Respiratory Diseases , Asthma Group Of The Chinese Thoracis Society , Chinese Throacic Society Asthma Group , National Medical Products Administration , American Thoracic Society Meeting , National Heart , Senior Vice President , Global Head , About Nucala , National Reimbursement Drug List , European Respiratory , Expert Rev Respir , Eur Respir , Efficacy Study , Subjects With Severe Asthma , Full Text View , Chinese Thoracis , Chinese Society , Chinese Journal , China Asthma Guideline , Add On Therapy , Chinese Patients With Severe Eosinophilic Asthma , Parallel Group Phase , Mepolizumab Treatment , Severe Eosinophilic , Glucocorticoid Sparing Effect , Lancet Respir , Nucala Full , Expert Opin Investig , Difficult To Treat Asthma , Noneosinophilic Asthma , Characterize Phenotypes , Global Real Life Severe Asthma ,